Skip to main navigation Skip to search Skip to main content

Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy☆

  • E. L. Mayer
  • , F. C. Bidard
  • , Y. H. Park
  • , W. Janni
  • , C. Ma
  • , M. Cristofanilli
  • , H. Iwata
  • , G. Bianchini
  • , K. Kalinsky
  • , S. Chia
  • , A. Brufsky
  • , P. A. Fasching
  • , Z. Nowecki
  • , S. C. Chen
  • , J. Pascual
  • , L. Moreau
  • , M. Ruiz-Borrego
  • , A. Shai
  • , N. Karadurmus
  • , J. H. Sohn
  • Y. Zhu, I. Leddin, M. S. Miralles, C. H. Bartlett, N. Turner

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy☆'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry